Routine Versus Selective Midtrimester Ultrasound in a Poorly Resourced Setting: a Cluster Randomised Controlled Trial
Fetal Congenital Abnormalities
Procedure: Routine midtrimester pregnany ultrasound scan
|Study Design:||Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Open Label
Primary Purpose: Diagnostic
- Detection of congenital abnormalities
- Postterm pregnancy inductions
- Detection of multiple pregnancies
- Neonatal morbidity
- Neonatal mortality
|Study Start Date:||June 2002|
|Estimated Study Completion Date:||May 2004|
Routine ultrasound scanning in the second trimester of pregnancy has few substantive benefits, according to the results of number of randomised trials, mostly performed in industrialised countries. While ultrasound did not seem to prevent fetal death, it was associated with improved detection of multiple pregnancies, improved detection of congenital abnormalities and reduced need for postterm labour induction. Only one trial, from Cape Town, has investigated the benefits of a policy of routine second trimester ultrasound scanning in an under-resourced setting.
This will be cluster randomised controlled trial, performed in the Krugersdorp area of South Africa, where most health service users are African, working class and dependent on government health facilities. About 900 low-risk pregnant women at less than 24 weeks gestation will be recruited, and randomised, in clusters, to either routine scanning or no scanning with recourse to selective scanning if clinically indicated.
Women will be followed up for maternal, fetal and neonatal outcome, and for indices of health service utilisation. Important outcome measures will be need for subsequent ultrasound,detection of multiple pregnancy, detection of congenital abnormalities, postterm pregnancy induction, still birth,and neonatal morbidity and mortality.
Data analysis will compare outcomes according to whether routine ultrasound scanning was or was not done, using standard statistical methods.
Please refer to this study by its ClinicalTrials.gov identifier: NCT00204139
|University of Johannesburg|
|Johannesburg, Gauteng, South Africa, 2000|
|Study Chair:||Eckhart J Buchmann, MBBCh||University of the Witwatersrand, Johannesburg|